PUT - SPRINTER OPEN END - PFIZER INC | Market Closed - Deutsche Boerse AG 18:46:54 17/05/2024 BST | ||
| 3.12 EUR | +0.32% |
|
| Current month | -10.60% | ||
| 1 month | -10.86% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 3.12 | +0.32% |
| 16/05/24 | 3.11 | +0.32% |
| 15/05/24 | 3.1 | -2.21% |
| 14/05/24 | 3.17 | 0.00% |
| 13/05/24 | 3.17 | -1.25% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 06:46 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | 
Vontobel
|
| WKN | VX4VWL |
| ISIN | DE000VX4VWL4 |
| Date issued | 17/12/2021 |
| Strike | 62.52 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.53 € |
|---|---|
| Lowest since issue | 0.47 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.64
USD
Average target price
31.94
USD
Spread / Average Target
+11.52%
- Stock Market
- Certificates
- Certificat
